Thursday, February 20, 2014 6:15:06 AM
In terms of dendritic cell therapy, I had the first six treatments in four weeks. I would receive the injection and then after an hour and a half, I would start getting a fever.Before I got home, I would have a fairly high fever. It wasn’t unpleasant—it never made me feel weak, whereas normally a fever might wear me down. Once I lay down and close my eyes, I always fall asleep fairly quickly. When I wake up the next day or night, it has already subsided a bit. I always develop a mild headache, but I don’t take anything for it because the headaches are bearable. I take it easy that day, go for a walk, and get some fresh air—and in the evening it’s gone.That’s it. Those are the only side effects I’ve ever experienced from this therapy.
— Karl-Heinz Hagemeyer, five-year survivor,Stage IIIb metastatic prostate cancer
After I had lung surgery to remove some additional tumors, we brought the material from the second lung to Cologne, because it contained active tumor cells. That tissue was used to make the dendritic cells.After I received the dendritic therapy, I recovered quickly and the next scans confirmed that all the cancer was gone. All the scans since then have been good news. The radiologist said: “We don’t believe in miracles, but this sure looks like one.”
— Wim Koosterboer, five-year survivor of hepatitis B andHBV-associated primary liver cancer (HCC) with lymph,liver and lung metastases
Dendritic cell therapy has no side effects for me, except for a touch of flu, which means that the treatment is catching on. It does cause a temporary fever, which usually starts about an hour after the injection.Over the course of eight hours, the fever rises a little, in my case up to about 39.5 C (102 F). Somehow it feels fine—I feel as though something positive is happening—I don’t feel ill. Although it’s a real fever, somehow my body knows that I need this. And the results are fantastic. My MRI scans over the past five years have confirmed that the treatment has been successful. In my case, the dendritic cell therapy’s symptoms were minimal and lasted no more than two days.The hyperthermia was uncomfortable for me personally, but it only took three hours. There were no side effects from the treatment. After that I felt better and could do what I wanted. So the treatment did not exhaust me and because I was not exhausted, it was much easier to stay optimistic.
— Harmen Wagenmakers, long-time survivor ofStage IV bile duct cancer (cholangiocarcinoma
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM